Acadia Pharmaceuticals | Capitale Di Prestito

Prezzo Delle Azioni
22.70
Cambio Giornaliero
-0.52 -2.24%
Mensile
-14.63%
Annuale
22.77%
Q1 Previsione
22.84




Capitale Di Prestito Cambiamento Data
Acadia Pharmaceuticals USD 0 0 2025-03
ALKERMES USD 285.82M 639K 2024-09
Alnylam Pharmaceuticals USD 1.04B 13.75M 2025-09
Biogen USD 6.29B 1.4M 2025-09
BioMarin Pharmaceutical USD 596.66M 501K 2025-09
Bristol-Myers Squibb USD 42.85B 1.62B 2025-12
Cara Therapeutics USD 0 0 2025-03
Cytokinetics USD 158.75M 554.3M 2025-09
Eisai JPY 134.77B 12M 2025-12
Eli Lilly USD 40.87B 6.69B 2025-09
Incyte USD 35.37M 3.61M 2025-09
J&J USD 39.41B 173M 2025-09
Moderna USD 26M 6M 2025-09
Neurocrine Biosciences USD 169.5M 500K 2023-03
Pfizer USD 57.41B 93M 2025-09
Prothena USD 0 0 2024-12
PTC Therapeutics USD 1.84B 298.68M 2025-09
Sarepta Therapeutics USD 1.04B 104.31M 2025-09
Ultragenyx Pharmaceutical USD 782.75M 11.3M 2025-06
Vanda Pharmaceuticals USD 3.15M 3.15M 2024-12
Vertex Pharmaceuticals USD 111.4M 1.4M 2025-03


Acadia Pharmaceuticals Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Feb 2026.